НовостиBenzingaTvardi Therapeutics Announces Publication Of Preclinical Data Evaluating Its STAT3 Inhibitor In International Journal Of Molecular Sciences Tvardi Therapeutics Announces Publication Of Preclinical Data Evaluating Its STAT3 Inhibitor In International Journal Of Molecular Sciences Benzinga 2026.09.24 12:04 (GMT+0) Открыть на Benzinga Другие новости